首页 | 本学科首页   官方微博 | 高级检索  
     

可溶性晚期糖基化终末产物受体拮抗缺血/再灌注小鼠心肌纤维化
引用本文:曹贤贤,韩雪洁,王红霞,曾翔俊,郭彩霞. 可溶性晚期糖基化终末产物受体拮抗缺血/再灌注小鼠心肌纤维化[J]. 解剖学报, 2021, 52(5): 772-776. DOI: 10.16098/j.issn.0529-1356.2021.05.015
作者姓名:曹贤贤  韩雪洁  王红霞  曾翔俊  郭彩霞
作者单位:1.首都医科大学附属北京同仁医院心血管中心,北京 100073; 2.首都医科大学生理学与病理生理学系,北京 100069
基金项目:国家自然科学基金;国家自然科学基金
摘    要:目的 探讨可溶性晚期糖基化终末产物受体(sRAGE)对缺血/再灌注小鼠心脏炎症的影响及其机制。 方法 利用6~8周龄雄性C57BL/6小鼠构建心肌缺血/再灌注损伤模型(左前降支结扎30 min,再灌注2周),随机分为4组,每组5只C57BL/6小鼠。通过心脏超声检测心功能,HE染色观察炎症细胞浸润情况,马松和天狼星红染色检测心肌纤维化,免疫组织化学染色检测半乳糖凝集素3(galecti-3)表达。 结果 与假手术组相比,缺血/再灌注组小鼠的心功能减退,心肌组织间有大量炎症细胞浸润,心肌纤维化面积增加,同时,心脏组织中 galectin-3 的表达增多;而给予外源性sRAGE处理后,小鼠的心功能显著改善,炎症细胞浸润减少,纤维化程度减轻,心脏组织中galecti-3的表达也显著减少。 结论 心肌缺血/再灌注损伤时,sRAGE可能通过抑制galectin-3的表达,减少小鼠心脏炎症细胞浸润,从而减轻心肌纤维化。

关 键 词:可溶性晚期糖基化终末产物受体   缺血/再灌注   纤维化   免疫组织化学   小鼠  
收稿时间:2020-04-05
修稿时间:2020-04-15

Soluble receptor for advanced glycation end-products inhibits myocardial fibrosis of ischemia/reperfusion mice
CAO Xian-xian,HAN Xue-jie,WANG Hong-xia,ZENG Xiang-jun,GUO Cai-xia. Soluble receptor for advanced glycation end-products inhibits myocardial fibrosis of ischemia/reperfusion mice[J]. Acta Anatomica Sinica, 2021, 52(5): 772-776. DOI: 10.16098/j.issn.0529-1356.2021.05.015
Authors:CAO Xian-xian  HAN Xue-jie  WANG Hong-xia  ZENG Xiang-jun  GUO Cai-xia
Affiliation:1.Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China; 2.Department of Physiology and Pathophysiology, Capital Medical University, Beijing 100069, China
Abstract:Objective To investigate the effect of soluble receptor for advanced glycation end-products (sRAGE) on inflammation in myocardial ischemia/reperfusion(I/R) mice and its mechanism. Methods Myocardial I/R injury model was conducted by left anterior descending ligation for 30 minutes and reperfusion for 2 weeks in male C57BL/6 mice aged 6-8 weeks. The mice were randomly divided into four groups with five C57BL/6 mice in each group. The cardiac function was detected by echocardiography, the inflammatory cells infiltration was observed by HE staining, the myocardial fibrosis was detected by Masson and Sirius red staining, the expression of galectin-3 was detected by immunohistochemical staining. Results Compared with the sham group, the cardiac function decreased, the inflammatory cells infiltrated increased among the myocardial tissue, the percentage of myocardial fibrosis area increased, and the expression of galectin-3 increased in I/R groups. After exogenous sRAGE treatment, the cardiac function of mice was significantly improved, the inflammatory cells infiltration decreased, the myocardial fibrosis area decreased, and the expression of galectin-3 decreased as well. Conclusion sRAGE may reduce inflammatory cells infiltration in mice heart by inhibiting the expression of galectin-3, and then alleviating myocardial fibrosis during myocardial ischemia/reperfusion injury.
Keywords:Soluble receptor for advanced glycation end-products   Ischemia/reperfusion   Fibrosis   Immunohistochemistry   Mouse  
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《解剖学报》浏览原始摘要信息
点击此处可从《解剖学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号